GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (MEX:TAK N) » Definitions » E10

Takeda Pharmaceutical Co (MEX:TAK N) E10 : MXN10.46 (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Takeda Pharmaceutical Co E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Takeda Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2025 was MXN-4.485. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is MXN10.46 for the trailing ten years ended in Mar. 2025.

During the past 12 months, Takeda Pharmaceutical Co's average E10 Growth Rate was 25.60% per year. During the past 3 years, the average E10 Growth Rate was 8.30% per year. During the past 5 years, the average E10 Growth Rate was 2.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Takeda Pharmaceutical Co was 8.30% per year. The lowest was -11.80% per year. And the median was -4.90% per year.

As of today (2025-07-03), Takeda Pharmaceutical Co's current stock price is MXN287.95. Takeda Pharmaceutical Co's E10 for the quarter that ended in Mar. 2025 was MXN10.46. Takeda Pharmaceutical Co's Shiller PE Ratio of today is 27.53.

During the past 13 years, the highest Shiller PE Ratio of Takeda Pharmaceutical Co was 36.90. The lowest was 19.53. And the median was 29.65.


Takeda Pharmaceutical Co E10 Historical Data

The historical data trend for Takeda Pharmaceutical Co's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co E10 Chart

Takeda Pharmaceutical Co Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.25 11.33 8.98 7.33 10.46

Takeda Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.33 7.22 9.31 9.21 10.46

Competitive Comparison of Takeda Pharmaceutical Co's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Shiller PE Ratio falls into.


;
;

Takeda Pharmaceutical Co E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Takeda Pharmaceutical Co's adjusted earnings per share data for the three months ended in Mar. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=-4.485/111.1000*111.1000
=-4.485

Current CPI (Mar. 2025) = 111.1000.

Takeda Pharmaceutical Co Quarterly Data

per share eps CPI Adj_EPS
201506 1.973 98.400 2.228
201509 2.652 98.500 2.991
201512 5.302 98.100 6.005
201603 -3.253 97.900 -3.692
201606 11.125 98.100 12.599
201609 3.002 98.000 3.403
201612 4.686 98.400 5.291
201703 -5.414 98.100 -6.131
201706 15.025 98.500 16.947
201709 2.922 98.800 3.286
201712 7.529 99.400 8.415
201803 -5.931 99.200 -6.642
201806 8.881 99.200 9.946
201809 5.129 99.900 5.704
201812 4.191 99.700 4.670
201903 -1.641 99.700 -1.829
201906 0.399 99.800 0.444
201909 3.980 100.100 4.417
201912 -1.787 100.500 -1.975
202003 0.115 100.300 0.127
202006 5.653 99.900 6.287
202009 0.269 99.900 0.299
202012 5.616 99.300 6.283
202103 11.776 99.900 13.096
202106 7.905 99.500 8.827
202109 2.714 100.100 3.012
202112 3.305 100.100 3.668
202203 -0.601 101.100 -0.660
202206 5.073 101.800 5.536
202209 2.771 103.100 2.986
202212 5.481 104.100 5.850
202303 1.301 104.400 1.384
202306 3.464 105.200 3.658
202309 -1.807 106.200 -1.890
202312 3.942 106.800 4.101
202403 -0.111 107.200 -0.115
202406 3.478 108.200 3.571
202409 3.937 108.900 4.017
202412 0.988 110.700 0.992
202503 -4.485 111.100 -4.485

Add all the adjusted EPS together and divide 10 will get our e10.


Takeda Pharmaceutical Co  (MEX:TAK N) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Takeda Pharmaceutical Co's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=287.95/10.46
=27.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Takeda Pharmaceutical Co was 36.90. The lowest was 19.53. And the median was 29.65.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Takeda Pharmaceutical Co E10 Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co Headlines

No Headlines